Company news
Insmed Incorporated news in 2019
Insmed Incorporated's news releases, calls and decks from 2019, newest first.
Insmed to Present at Two December Conferences
November 25, 2019
Insmed Appoints Dr. Clarissa Desjardins to its Board of Directors and Names Roger Adsett Chief Operating Officer
November 13, 2019
Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update
October 29, 2019
Insmed to Host Third Quarter 2019 Financial Results Conference Call on Wednesday, October 30, 2019
October 22, 2019
Insmed to Present at Two September Conferences
September 2, 2019
Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update
July 31, 2019
Insmed to Host Second Quarter 2019 Financial Results Conference Call on Thursday, August 1, 2019
July 24, 2019
Insmed Announces Closing of Public Offering of Common Stock
June 25, 2019
Insmed Granted Additional U.S. Patent For ARIKAYCE® (amikacin liposome inhalation suspension), Strengthening Brand's Global Patent Portfolio
April 8, 2019
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch
April 7, 2019
Insmed To Showcase New ARIKAYCE® (amikacin liposome inhalation suspension) And Pipeline Data At American Thoracic Society International Conference
March 31, 2019
Insmed to Present at the H.C. Wainwright Global Life Sciences Conference
March 31, 2019
Decks in 2019
- Investor Presentation (January 2019)
Investor deck · 20 slides · Jan 7, 2019